Active Ingredient Risankizumab
Active Ingredient Details
How many products in the NDC database contain Risankizumab?
The NDC database has 17 products with the active ingredient Risankizumab. The following table lists all the products that have this active ingredient.
NDC Products with Risankizumab
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
0074-1050 | Proprietary Name: Skyrizi | Risankizumab-rzaa | Injection | Subcutaneous | Abbvie Inc. | ACTIVE | |
0074-1058 | Proprietary Name: | Risankizumab | Injection, Solution | Abbvie Inc. | ACTIVE | ||
0074-1059 | Proprietary Name: | Risankizumab | Liquid | Abbvie Inc. | ACTIVE | ||
0074-1078 | Proprietary Name: | Risankizumab | Liquid | Abbvie Inc. | ACTIVE | ||
0074-2100 | Proprietary Name: Skyrizi | Risankizumab-rzaa | Injection | Subcutaneous | Abbvie Inc. | ACTIVE | |
0074-5015 | Proprietary Name: Skyrizi | Risankizumab-rzaa | Injection | Intravenous | Abbvie Inc. | ACTIVE | |
0074-5016 | Proprietary Name: | Risankizumab | Injection, Solution | Abbvie Inc. | ACTIVE | ||
0074-5025 | Proprietary Name: | Risankizumab | Injection, Solution | Abbvie Inc. | ACTIVE | ||
0074-9000 | Proprietary Name: | Risankizumab | Injection, Solution | Abbvie Inc. | ACTIVE | ||
0074-9010 | Proprietary Name: | Risankizumab | Injection, Solution | Abbvie Inc. | ACTIVE | ||
0074-9011 | Proprietary Name: | Risankizumab | Liquid | Abbvie Inc. | ACTIVE | ||
12714-215 | Proprietary Name: | Risankizumbab | Liquid | Boehringer Ingelheim Pharma Gmbh And Co. Kg | ACTIVE | ||
12714-216 | Proprietary Name: | Risankizumbab | Liquid | Boehringer Ingelheim Pharma Gmbh And Co. Kg | ACTIVE | ||
12714-217 | Proprietary Name: | Risankizumbab | Solution | Boehringer Ingelheim Pharma Gmbh And Co. Kg | ACTIVE | ||
68225-226 | Proprietary Name: | Risankizumab | Injection, Solution | Patheon Italia S.p.a. | ACTIVE | ||
68225-227 | Proprietary Name: | Risankizumab | Injection, Solution | Patheon Italia S.p.a. | ACTIVE | ||
68225-233 | Proprietary Name: | Risankizumab | Injection, Solution | Patheon Italia S.p.a. | ACTIVE |